MARIETTA, Ga., July 26, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today provided an update concerning the status of its compliance with the Listing Rules of the Nasdaq Stock Market. On July 10, 2018, MiMedx notified the Nasdaq staff that the Company will be unable to bring its SEC […]